Keywords: نظارت پس از بازاریابی; AEFI; Adverse events following immunization; ICD; International Classification of Diseases; ITP; Immune thrombocytopenic purpura; LMIC; Low and middle-income countries; MMR; Measles-mumps-rubella; PAHO/WHO; Pan American Health Organization; SCCS; Self-con
مقالات ISI نظارت پس از بازاریابی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نظارت پس از بازاریابی; Post-marketing surveillance; Vaccine safety; Global Vaccine Safety Initiative (GVSI); Adverse events following immunization (AEFI); AEFI; adverse events following immunization; AM; aseptic meningitis; CRF; case report form; GVSI; Global Vaccine Safety Ini
Keywords: نظارت پس از بازاریابی; Post-marketing surveillance; Vaccine safety; Global Vaccine Safety Initiative (GVSI); Adverse events following immunization (AEFI); AEFI; adverse events following immunization; AM; aseptic meningitis; CI; Confidence Interval; CSF; cerebrospinal fluid; EMC
Keywords: نظارت پس از بازاریابی; European registries; Arthroplasty registry; Hip arthroplasty; Knee arthroplasty; Post-marketing surveillance; Medical devices; Health technology assessment;
Keywords: نظارت پس از بازاریابی; Pharmacoepidemiology; Post-marketing surveillance; Saudi Arabia; Pharmacovigilance; ADRs;
Keywords: نظارت پس از بازاریابی; Antivenom; Pre-clinical testing; Clinical trials; Placebo control; Ethical considerations; Adverse reactions; Randomized controlled trials; Blinding; Post-marketing surveillance;
Keywords: نظارت پس از بازاریابی; Herbal drug; Adverse drug reaction; Pharmacovigilance; Post-marketing surveillance; Herbal medicine; Korean medicine;
Keywords: نظارت پس از بازاریابی; Acute otitis media; Pneumococcal conjugate vaccines; PHiD-CV; 13vCRM; Post-marketing surveillance; Observational studies;
Keywords: نظارت پس از بازاریابی; Drug safety warnings; Utilisation; Regulation; Post-marketing surveillance; Denmark; Germany;
Keywords: نظارت پس از بازاریابی; Influenza; Post-marketing surveillance; Peramivir; High risk; Safety profile;
Keywords: نظارت پس از بازاریابی; Natural language processing; Text mining; Network analysis; Post-marketing surveillance; Information retrieval;
Keywords: نظارت پس از بازاریابی; Natural language processing; Post-marketing surveillance; Temporal information;
Keywords: نظارت پس از بازاریابی; Abuse deterrence; Tamper-resistant formulations; Pharmaceutical opioids; Injecting drug use; Opioid dependence; Post-marketing surveillance
Keywords: نظارت پس از بازاریابی; Live-attenuated Japanese encephalitis vaccine; Post-marketing surveillance; Safety;
Keywords: نظارت پس از بازاریابی; Opioid substitution therapy; Methadone; Compliance; Abuse liability; Post-marketing surveillance;
Keywords: نظارت پس از بازاریابی; Pharmacovigilance; Post-marketing surveillance; Novel data sources
Keywords: نظارت پس از بازاریابی; Regulatory science; Drug development; Benefit-risk assessment; Market authorization; Post-marketing surveillance;
Keywords: نظارت پس از بازاریابی; Vaccine regulation; Clinical trials; Post-marketing surveillance; Vaccine quality; Correlates of immunity; Vaccine standardization;
Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015
Keywords: نظارت پس از بازاریابی; Vaccine safety; Hepatitis B vaccines; Post-marketing surveillance;
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance
Keywords: نظارت پس از بازاریابی; Mycobacterium avium complex; Mycobacterium avium; Mycobacterium intracellulare; Post-marketing surveillance;
Clinical safety and efficacy of “filgrastim biosimilar 2” in Japanese patients in a post-marketing surveillance study
Keywords: نظارت پس از بازاریابی; Filgrastim; Biosimilar; Post-marketing surveillance; Neutropenia;
Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine
Keywords: نظارت پس از بازاریابی; Post-marketing surveillance; Vaccine safety; Pertussis; Tdap; Pregnancy; Maternal; AHR; adjusted hazard ratio; BMI; body mass index; CI; confidence interval; HR; hazard ratio; ID; identifiers; IMMS; Immunisation Subsidies Collection; ICD-10-AM; Internatio
Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
Keywords: نظارت پس از بازاریابی; Atrial fibrillation; Anticoagulants; Post-marketing surveillance; Dabigatran; Japan
Diagnostic efficacy and safety of gadoteric acid MR mammography in 1537 patients
Keywords: نظارت پس از بازاریابی; MR mammography; Gadoteric acid; Gadoterate meglumine; Post-marketing surveillance; Efficacy; Adverse drug reactions;
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation
Keywords: نظارت پس از بازاریابی; Influenza; Post-marketing surveillance; Peramivir; Pediatric; Safety profile; Abnormal behavior
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
Keywords: نظارت پس از بازاریابی; Idiopathic pulmonary fibrosis; Pirfenidone; Post-marketing surveillance; Safety
The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study
Keywords: نظارت پس از بازاریابی; Pharmaceutical opioids; Post-marketing surveillance; Abuse deterrence; Tamper resistance; Opioid dependence; Injecting drug use;
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): A drug use investigation
Keywords: نظارت پس از بازاریابی; Influenza; Peramivir; Post-marketing surveillance; Safety profile;
Febrile seizures after 2010–2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system
Keywords: نظارت پس از بازاریابی; Febrile seizure; Trivalent influenza vaccine; Vaccine safety; Post-marketing surveillance
Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians
Keywords: نظارت پس از بازاریابی; Buprenorphine; Buprenorphine/naloxone; Suboxone; Survey; Abuse; Diversion; Risk management; Post-marketing surveillance
Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: Benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines
Keywords: نظارت پس از بازاریابی; Intussusception; Rotavirus vaccines; Post-marketing surveillance
Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance
Keywords: نظارت پس از بازاریابی; Laninamivir; Safety; Abnormal behaviour; Post-marketing surveillance
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants
Keywords: نظارت پس از بازاریابی; Depression; Antidepressants; Antidepressant effects; Post-marketing surveillance;
Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia
Keywords: نظارت پس از بازاریابی; Rotavirus vaccine; Intussusception; Post-marketing surveillance; RotaTeq®; Rotarix®; Immunization
Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse
Keywords: نظارت پس از بازاریابی; Substance related disorders; Doctor shopping; Clustering method; Prescription drug abuse; Pharmacoepidemiology; Drug reimbursement database; High Dosage Buprenorphine; Post-marketing surveillance
The role of adverse events and related safety data in the pre-market evaluation of drug abuse potential
Keywords: نظارت پس از بازاریابی; Abuse potential; Adverse events; Post-marketing surveillance; Clinical trials;
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010
Keywords: نظارت پس از بازاریابی; H1N1 vaccines; Vaccine safety; Post-marketing surveillance
Surveillance of adverse fetal effects of medications (SAFE-Med): Findings from the International Clearinghouse of Birth Defects Surveillance and Research
Keywords: نظارت پس از بازاریابی; Teratogen; Drug; Medication; Post-marketing surveillance; Birth defect; Preconception
Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
Keywords: نظارت پس از بازاریابی; Influenza; Inactivated subunit influenza vaccine; Immunogenicity; Safety; Reactogenicity; Post-marketing surveillance
Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
Keywords: نظارت پس از بازاریابی; CV, cardiovascular; DIG, digestive; ENDO, endocrine; HAL, heme and lymphatic; MAN, metabolic and nutritional; MS, musculoskeletal; NER, nervous; RES, respiratory; SKIN, skin; SS, specialInfluenza vaccines; Vaccine safety; Post-marketing surveillance
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2007
Keywords: نظارت پس از بازاریابی; Anthrax vaccine; Post-marketing surveillance; VAERS
Case histories in pharmaceutical risk management
Keywords: نظارت پس از بازاریابی; Abuse liability; Regulation; Post-marketing surveillance; Risk management; REMS; Medications; Opioids; Oxycodone; Buprenorphine; Amphetamine; Methylphenidate; Sodium oxybate; Lisdexamfetamine; Food and Drug Administration
Association between non-medical and prescriptive usage of opioids
Keywords: نظارت پس از بازاریابی; Abuse; Opioids; Prescription medications; Pain; Abuse liability; Post-marketing surveillance